Visalytics
Visalytics
approved EB-2 (NIW)

Physician

Gastroenterology And Oncology · Malaysia · 2025-09-21

Processing Time
5 days
Decision Date
2025-09-21
Location
Washington
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in pharmacoepidemiology, specifically focusing on the relationship between mRNA vaccines and gastrointestinal diseases such as ulcerative colitis flare-ups. His work aims to investigate gastrointestinal bleeding outcomes in hospital admissions to develop effective therapeutic strategies and improve patient safety.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent healthcare priorities and vaccine safety, which have broad implications for U.S. public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's M.D., publication record, and 180 citations demonstrate his ability to drive advances in his specialized field.

3 Waiver Benefit Met

On balance, the petitioner's unique expertise in pharmacoepidemiology and his contributions to patient safety justify waiving the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. degree and his record of 8 peer-reviewed journal articles and 24 conference abstracts. His work earned 180 citations and he completed at least 8 peer reviews for scholarly journals. The case was supported by six recommendation letters from international experts, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Assistant Professor

Healthcare · India

WeGreened EB-2 (NIW) approved
Arizona 50 days 2025-03-13
The petitioner proposes to continue his research addressing critical clinical problems in internal medicine, specifically focusing on infectious, gastrointestinal, and hematology-oncology diseases to improve patient outcomes and guide clinical strategies during global health crises.
View Case

Others

Healthcare · India

WeGreened EB-2 (NIW) approved
Minnesota 97 days 2025-01-24
The petitioner proposes to advance research focused on developing cutting-edge molecular diagnostic tools, pioneering innovative treatment strategies, and implementing comprehensive patient care models. Specifically, the work aims to study risk factors and transform the early diagnosis and management of gastrointestinal and liver diseases, including cancer.
View Case

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
213 days 2025-07-08
The petitioner proposes to use multi-omics tools to investigate disease mechanisms, specifically focusing on inflammatory bowel disease (IBD) and gastrointestinal cancers. This work aims to develop healthcare solutions for chronic conditions and improve public health outcomes through precision medicine.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Malaysia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Malaysia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist